Anoikis: An emerging hallmark in health and diseases

Journal of Pathology

Volumn 226, Issue 2, 2012, Pages 380-393

  Taddei, M L ^a,b   Giannoni, E ^a,b   Fiaschi, T ^a,b   Chiarugi, P ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Transfer and High Education for the Development of De Novo Therapies (DENOTHE)   (Italy)

Author keywords

anoikis; anoikis resistance; cancer; cardiovascular diseases; diabetes

Indexed keywords

BIM PROTEIN; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; CYTOCHROME C; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; FOCAL ADHESION KINASE; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; PAXILLIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN NOXA; PUMA PROTEIN; SCATTER FACTOR RECEPTOR; SCLEROPROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANOIKIS; APOPTOSIS; CARDIOVASCULAR DISEASE; CELL ADHESION; CELL DISRUPTION; CELL GROWTH; CELL INTERACTION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; DIABETES MELLITUS; DIABETIC RETINOPATHY; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; LYMPHOCYTE; METASTASIS; MITOCHONDRIAL MEMBRANE; NEOPLASM; OXIDATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ANOIKIS; CARDIOVASCULAR DISEASES; CELL TRANSPLANTATION; DIABETES MELLITUS; HUMANS; NEOPLASMS;

EID: 82755190844     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.3000     Document Type: Review

References (180)

1. Frisch SM, Francis H,. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994; 124: 619-626. (Pubitemid 24064472)
2. Giancotti FG,. Complexity and specificity of integrin signalling. Nat Cell Biol 2000; 2: E13-14.
3. Danial NN, Korsmeyer SJ,. Cell death: critical control points. Cell 2004; 116: 205-219. (Pubitemid 38167313)
4. Gilmore AP,. Anoikis. Cell Death Differ 2005; 12 (suppl 2): 1473-1477. (Pubitemid 41553981)
5. Grossmann J,. Molecular mechanisms of 'detachment-induced apoptosis-anoikis'. Apoptosis 2002; 7: 247-260.
6. Reddig PJ, Juliano RL,. Clinging to life: cell to matrix adhesion and cell survival. Cancer Metast Rev 2005; 24: 425-439. (Pubitemid 41569982)
7. Green DR,. Apoptotic pathways: paper wraps stone blunts scissors. Cell 2000; 102: 1-4.
8. Martinou JC, Green DR,. Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2001; 2: 63-67. (Pubitemid 33676963)
9. Shimizu S, Narita M, Tsujimoto Y,. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1999; 399: 483-487. (Pubitemid 29258855)
10. Baines CP, Kaiser RA, Sheiko T, et al., Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 2007; 9: 550-555. (Pubitemid 46696536)
11. Cohen GM,. Caspases: the executioners of apoptosis. Biochem J 1997; 326: 1-16. (Pubitemid 27386911)
12. Thornberry NA,. Caspases: key mediators of apoptosis. Chem Biol 1998; 5: R97-103. (Pubitemid 28259737)
13. Zou H, Henzel WJ, Liu X, et al., Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997; 90: 405-413. (Pubitemid 27347231)
14. Valentijn AJ, Gilmore AP,. Translocation of full-length Bid to mitochondria during anoikis. J Biol Chem 2004; 279: 32848-32857. (Pubitemid 39014745)
15. Bouillet P, Strasser A,. BH3-only proteins-evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. J Cell Sci 2002; 115: 1567-1574. (Pubitemid 34520586)
16. Taylor RC, Cullen SP, Martin SJ,. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008; 9: 231-241. (Pubitemid 351301823)
17. Cheng EH, Wei MC, Weiler S, et al., BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 2001; 8: 705-711. (Pubitemid 32946946)
18. Le Gall M, Chambard JC, Breittmayer JP, et al., The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal. Mol Biol Cell 2000; 11: 1103-1112. (Pubitemid 30159325)
19. Qi XJ, Wildey GM, Howe PH,. Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function. J Biol Chem 2006; 281: 813-823.
20. Belzacq AS, Vieira HL, Kroemer G, et al., The adenine nucleotide translocator in apoptosis. Biochimie 2002; 84: 167-176.
21. Van der Heiden MG, Chandel NS, Williamson EK, et al., Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 1997; 91: 627-637. (Pubitemid 27513654)
22. Kuwana T, Bouchier-Hayes L, Chipuk JE, et al., BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 2005; 17: 525-535. (Pubitemid 40269117)
23. Letai A, Bassik MC, Walensky LD, et al., Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2002; 2: 183-192. (Pubitemid 41043974)
24. Cory S, Huang DC, Adams JM,. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003; 22: 8590-8607. (Pubitemid 38028528)
25. Green DR, Kroemer G,. The pathophysiology of mitochondrial cell death. Science 2004; 305: 626-629. (Pubitemid 39006738)
26. Gazaryan IG, Brown AM,. Intersection between mitochondrial permeability pores and mitochondrial fusion/fission. Neurochem Res 2007; 32: 917-929. (Pubitemid 46481317)
27. Nakano K, Vousden KH,. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 2001; 7: 683-694. (Pubitemid 32706359)
28. Shibue T, Takeda K, Oda E, et al., Integral role of Noxa in p53-mediated apoptotic response. Genes Dev 2003; 17: 2233-2238. (Pubitemid 37128638)
29. Puthalakath H, Villunger A, O'Reilly LA, et al., Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science 2001; 293: 1829-1832. (Pubitemid 32845780)
30. Hausmann M, Leucht K, Ploner C, et al., BCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cells. J Biol Chem 2011; 286: 26533-26540.
31. Wajant H,. The Fas signaling pathway: more than a paradigm. Science 2002; 296: 1635-1636. (Pubitemid 34579146)
32. Gilley J, Coffer PJ, Ham J,. FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 2003; 162: 613-622. (Pubitemid 37022939)
33. Ley R, Balmanno K, Hadfield K, et al., Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. J Biol Chem 2003; 278: 18811-18816. (Pubitemid 36799262)
34. Shimamura A, Ballif BA, Richards SA, et al., Rsk1 mediates a MEK-MAP kinase cell survival signal. Curr Biol 2000; 10: 127-135. (Pubitemid 30115743)
35. Zha J, Harada H, Yang E, et al., Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996; 87: 619-628. (Pubitemid 26386936)
36. Valentijn AJ, Gilmore AP,. Translocation of full-length Bid to mitochondria during anoikis. J Biol Chem 2004; 279: 32848-32857. (Pubitemid 39014745)
37. Aoudjit F, Vuori K,. Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-flip and implications for anoikis. J Cell Biol 2001; 152: 633-643. (Pubitemid 34280244)
38. Chen CS, Mrksich M, Huang S, et al., Geometric control of cell life and death. Science 1997; 276: 1425-1428. (Pubitemid 27235413)
39. Muzio M, Stockwell BR, Stennicke HR, et al., An induced proximity model for caspase-8 activation. J Biol Chem 1998; 273: 2926-2930. (Pubitemid 28133943)
40. Scaffidi C, Fulda S, Srinivasan A, et al., Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998; 17: 1675-1687. (Pubitemid 28119121)
41. Crouch DH, Fincham VJ, Frame MC,. Targeted proteolysis of the focal adhesion kinase pp125 FAK during c-MYC-induced apoptosis is suppressed by integrin signalling. Oncogene 1996; 12: 2689-2696. (Pubitemid 26237798)
42. Shim SR, Kook S, Kim JI, et al., Degradation of focal adhesion proteins paxillin and p130cas by caspases or calpains in apoptotic rat-1 and L929 cells. Biochem Biophys Res Commun 2001; 286: 601-608. (Pubitemid 32912989)
43. Widmann C, Gibson S, Johnson GL,. Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J Biol Chem 1998; 273: 7141-7147. (Pubitemid 28160387)
44. Alahari SK, Reddig PJ, Juliano RL,. Biological aspects of signal transduction by cell adhesion receptors. Int Rev Cytol 2002; 220: 145-184. (Pubitemid 34988797)
45. Kim W, Kook S, Kim DJ, et al., The 31 kDa caspase-generated cleavage product of p130cas functions as a transcriptional repressor of E2A in apoptotic cells. J Biol Chem 2004; 279: 8333-8342. (Pubitemid 38294725)
46. Thompson EW, Newgreen DF, Tarin D,. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 2005; 65: 5991-5995. (Pubitemid 40994377)
47. Zanotti S, Gibertini S, Bragato C, et al., Fibroblasts from the muscles of Duchenne muscular dystrophy patients are resistant to cell detachment apoptosis. Exp Cell Res 2011; 317: 2536-2547.
48. Giannoni E, Buricchi F, Grimaldi G, et al., Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival. Cell Death Differ 2008; 15: 867-878. (Pubitemid 351524429)
49. Meredith JE Jr, Fazeli B, Schwartz MA,. The extracellular matrix as a cell survival factor. Mol Biol Cell 1993; 4: 953-961. (Pubitemid 23309430)
50. Bissell MJ, Radisky D,. Putting tumours in context. Nat Rev Cancer 2001; 1: 46-54. (Pubitemid 33741880)
51. Guo W, Giancotti FG,. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004; 5: 816-826. (Pubitemid 39336275)
52. Ramsay AG, Marshall JF, Hart IR,. Integrin trafficking and its role in cancer metastasis. Cancer Metast Rev 2007; 26: 567-578. (Pubitemid 350115108)
53. Hanks SK, Ryzhova L, Shin NY, et al., Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. Front Biosci 2003; 8: d982-996. (Pubitemid 38943176)
54. Ilic D, Almeida EA, Schlaepfer DD, et al., Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J Cell Biol 1998; 143: 547-560. (Pubitemid 28487870)
55. Cardone MH, Roy N, Stennicke HR, et al., Regulation of cell death protease caspase-9 by phosphorylation. Science 1998; 282: 1318-1321. (Pubitemid 28524494)
56. Datta SR, Katsov A, Hu L, et al., 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell 2000; 6: 41-51.
57. Romashkova JA, Makarov SS,. NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999; 401: 86-90.
58. Kops GJ, Burgering BM,. Forkhead transcription factors: new insights into protein kinase B (c-akt) signaling. J Mol Med 1999; 77: 656-665. (Pubitemid 29500958)
59. Attwell S, Roskelley C, Dedhar S,. The integrin-linked kinase (ILK) suppresses anoikis. Oncogene 2000; 19: 3811-3815. (Pubitemid 30621188)
60. Persad S, Attwell S, Gray V, et al., Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci USA 2000; 97: 3207-3212. (Pubitemid 30183280)
61. Barberis L, Wary KK, Fiucci G, et al., Distinct roles of the adaptor protein Shc and focal adhesion kinase in integrin signaling to ERK. J Biol Chem 2000; 275: 36532-36540. (Pubitemid 32002050)
62. Wary KK, Mariotti A, Zurzolo C, et al., A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 1998; 94: 625-634. (Pubitemid 28427581)
63. Moro L, Venturino M, Bozzo C, et al., Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. EMBO J 1998; 17: 6622-6632. (Pubitemid 28521796)
64. Wang CZ, Hsu YM, Tang MJ,. Function of discoidin domain receptor I in HGF-induced branching tubulogenesis of MDCK cells in collagen gel. J Cell Physiol 2005; 203: 295-304.
65. Soldi R, Mitola S, Strasly M, et al., Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 1999; 18: 882-892. (Pubitemid 29082268)
66. Sundberg C, Rubin K,. Stimulation of beta1 integrins on fibroblasts induces PDGF independent tyrosine phosphorylation of PDGF β-receptors. J Cell Biol 1996; 132: 741-752.
67. Shen X, Kramer RH,. Adhesion-mediated squamous cell carcinoma survival through ligand-independent activation of epidermal growth factor receptor. Am J Pathol 2004; 165: 1315-1329. (Pubitemid 39297736)
68. Moro L, Dolce L, Cabodi S, et al., Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines. J Biol Chem 2002; 277: 9405-9414. (Pubitemid 34953026)
69. Giannoni E, Fiaschi T, Ramponi G, et al., Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals. Oncogene 2009; 28: 2074-2086.
70. Fung C, Lock R, Gao S, et al., Induction of autophagy during extracellular matrix detachment promotes cell survival. Mol Biol Cell 2008; 19: 797-806. (Pubitemid 351481798)
71. Horbinski C, Mojesky C, Kyprianou N,. Live free or die: tales of homeless (cells) in cancer. Am J Pathol 2010; 177: 1044-1052.
72. Avivar-Valderas A, Salas E, Bobrovnikova-Marjon E, et al., PERK integrates autophagy and oxidative stress responses to promote survival during ECM detachment. Mol Cell Biol 2011; 31: 3616-3629.
73. Zhou F, Yang Y, Xing D,. Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. FEBS J 2011; 278: 403-413.
74. Lock R, Debnath J,. Extracellular matrix regulation of autophagy. Curr Opin Cell Biol 2008; 20: 583-588.
75. Chambers AF, Groom AC, MacDonald IC,. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2: 563-572. (Pubitemid 37328923)
76. Nguyen DX, Bos PD, Massague J,. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009; 9: 274-284.
77. Hynes RO,. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11-25.
78. Shapiro L, Fannon AM, Kwong PD, et al., Structural basis of cell-cell adhesion by cadherins. Nature 1995; 374: 327-337.
79. Carter WG, Wayner EA, Bouchard TS, et al., The role of integrins α2β1 and α3β1 in cell-cell and cell-substrate adhesion of human epidermal cells. J Cell Biol 1990; 110: 1387-1404.
80. Watt FM,. Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J 2002; 21: 3919-3926. (Pubitemid 34857425)
81. Breuss JM, Gallo J, DeLisser HM, et al., Expression of the β6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci 1995; 108: 2241-2251.
82. Haapasalmi K, Zhang K, Tonnesen M, et al., Keratinocytes in human wounds express αvβ6 integrin. J Invest Dermatol 1996; 106: 42-48. (Pubitemid 26052049)
83. Jones J, Watt FM, Speight PM,. Changes in the expression of αv integrins in oral squamous cell carcinomas. J Oral Pathol Med 1997; 26: 63-68. (Pubitemid 27157727)
84. Regezi JA, Ramos DM, Pytela R, et al., Tenascin and β6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas. Oral Oncol 2002; 38: 332-336. (Pubitemid 34655686)
85. van der Flier A, Sonnenberg A,. Function and interactions of integrins. Cell Tissue Res 2001; 305: 285-298. (Pubitemid 34212122)
86. Albelda SM, Mette SA, Elder DE, et al., Integrin distribution in malignant melanoma: association of the β3 subunit with tumor progression. Cancer Res 1990; 50: 6757-6764. (Pubitemid 20348810)
87. Melchiori A, Mortarini R, Carlone S, et al., The α3β1 integrin is involved in melanoma cell migration and invasion. Exp Cell Res 1995; 219: 233-242.
88. Natali PG, Nicotra MR, Bartolazzi A, et al., Integrin expression in cutaneous malignant melanoma: association of the α3/β1 heterodimer with tumor progression. Int J Cancer 1993; 54: 68-72. (Pubitemid 23137001)
89. Montgomery AM, Reisfeld RA, Cheresh DA,. Integrin αvβ3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci USA 1994; 91: 8856-8860. (Pubitemid 2148815)
90. Petitclerc E, Stromblad S, von Schalscha TL, et al., Integrin α(v)β3 promotes M21 melanoma growth in human skin by regulating tumor cell survival. Cancer Res 1999; 59: 2724-2730. (Pubitemid 29269122)
91. Burnier JV, Wang N, Michel RP, et al., Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis. Oncogene 2011; 30: 3766-3783.
92. Wei L, Yang Y, Zhang X, et al., Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis. Oncogene 2004; 23: 9052-9061. (Pubitemid 40013072)
93. 2 ratio and confers anoikis resistance to tumors. Cancer Cell 2011; 19: 401-415.
94. Mackey AM, Sanvicens N, Groeger G, et al., Redox survival signalling in retina-derived 661 W cells. Cell Death Differ 2008; 15: 1291-1303. (Pubitemid 351984758)
95. Rungtabnapa P, Nimmannit U, Halim H, et al., Hydrogen peroxide inhibits non-small cell lung cancer cell anoikis through the inhibition of caveolin-1 degradation. Am J Physiol Cell Physiol 2011; 300: C235-245.
96. Blanco MJ, Moreno-Bueno G, Sarrio D, et al., Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 2002; 21: 3241-3246. (Pubitemid 34548095)
97. Vega S, Morales AV, Ocana OH, et al., Snail blocks the cell cycle and confers resistance to cell death. Genes Dev 2004; 18: 1131-1143. (Pubitemid 38669034)
98. Sosic D, Richardson JA, Yu K, et al., Twist regulates cytokine gene expression through a negative feedback loop that represses NF-κB activity. Cell 2003; 112: 169-180. (Pubitemid 36144107)
99. Cowin P, Rowlands TM, Hatsell SJ,. Cadherins and catenins in breast cancer. Curr Opin Cell Biol 2005; 17: 499-508. (Pubitemid 41267164)
100. Derksen PW, Liu X, Saridin F, et al., Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 2006; 10: 437-449. (Pubitemid 44693469)
101. Onder TT, Gupta PB, Mani SA, et al., Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008; 68: 3645-3654.
102. Tamura G, Yin J, Wang S, et al., E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 2000; 92: 569-573. (Pubitemid 30212319)
103. Cavallaro U, Christofori G,. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004; 4: 118-132. (Pubitemid 38198740)
104. Kanayama S, Yamada Y, Kawaguchi R, et al., Hepatocyte growth factor induces anoikis resistance by up-regulation of cyclooxygenase-2 expression in uterine endometrial cancer cells. Oncol Rep 2008; 19: 117-122. (Pubitemid 351176139)
105. Mani SA, Guo W, Liao MJ, et al., The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715. (Pubitemid 351636299)
106. Polyak K, Weinberg RA,. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009; 9: 265-273.
107. Giannoni E, Bianchini F, Masieri L, et al., Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res 2010; 70: 6945-6956.
108. Gupta PB, Chaffer CL, Weinberg RA,. Cancer stem cells: mirage or reality? Nat Med 2009; 15: 1010-1012.
109. Giannoni E, Bianchini F, Calorini L, et al., Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness. Antioxid Redox Signal 2011; 14: 2361-2371.
110. Parri M, Taddei ML, Bianchini F, et al., EphA2 re-expression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style. Cancer Res 2009; 69: 2072-2081.
111. Taddei ML, Parri M, Angelucci A, et al., EphA2 induces metastatic growth regulating amoeboid motility and clonogenic potential in prostate carcinoma cells. Mol Cancer Res 2011; 9: 149-160.
112. Pasquale EB,. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer 2010; 10: 165-180.
113. Harada K, Hiramoto-Yamaki N, Negishi M, et al., Ephexin4 and EphA2 mediate resistance to anoikis through RhoG and phosphatidylinositol 3-kinase. Exp Cell Res 2011; 317: 1701-1713.
114. Diaz-Montero CM, Wygant JN, McIntyre BW,. PI3-K/Akt-mediated anoikis resistance of human osteosarcoma cells requires Src activation. Eur J Cancer 2006; 42: 1491-1500. (Pubitemid 43903158)
115. Duxbury MS, Ito H, Benoit E, et al., A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells. Cancer Res 2004; 64: 3987-3993. (Pubitemid 38697314)
116. Hlobilkova A, Knillova J, Bartek J, et al., The mechanism of action of the tumour suppressor gene PTEN. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003; 147: 19-25.
117. Davies MA, Koul D, Dhesi H, et al., Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res 1999; 59: 2551-2556. (Pubitemid 29269096)
118. Sakamoto S, Kyprianou N,. Targeting anoikis resistance in prostate cancer metastasis. Mol Aspects Med 2010; 31: 205-214.
119. Khwaja A, Rodriguez-Viciana P, Wennstrom S, et al., Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 1997; 16: 2783-2793. (Pubitemid 27226215)
120. Rosen K, Rak J, Jin J, et al., Downregulation of the pro-apoptotic protein Bak is required for the ras-induced transformation of intestinal epithelial cells. Curr Biol 1998; 8: 1331-1334. (Pubitemid 29006709)
121. Rosen K, Rak J, Leung T, et al., Activated Ras prevents downregulation of Bcl-X(L) triggered by detachment from the extracellular matrix. A mechanism of Ras-induced resistance to anoikis in intestinal epithelial cells. J Cell Biol 2000; 149: 447-456.
122. Ma Z, Liu Z, Wu RF, et al., p66(Shc) restrains Ras hyperactivation and suppresses metastatic behavior. Oncogene 2010; 29: 5559-5567.
123. Nesbit M, Nesbit HK, Bennett J, et al., Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes. Oncogene 1999; 18: 6469-6476.
124. Li G, Satyamoorthy K, Meier F, et al., Function and regulation of melanoma-stromal fibroblast interactions: when seeds meet soil. Oncogene 2003; 22: 3162-3171. (Pubitemid 36713768)
125. Brodeur GM, Nakagawara A, Yamashiro DJ, et al., Expression of TrkA, TrkB and TrkC in human neuroblastomas. J Neurooncol 1997; 31: 49-55. (Pubitemid 27077709)
126. Dionne CA, Camoratto AM, Jani JP, et al., Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587). Clin Cancer Res 1998; 4: 1887-1898. (Pubitemid 28369172)
127. Sclabas GM, Fujioka S, Schmidt C, et al., Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells. Clin Cancer Res 2005; 11: 440-449. (Pubitemid 40116865)
128. Douma S, Van LT, Zevenhoven J, et al., Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 2004; 430: 1034-1039.
129. Smit MA, Geiger TR, Song JY, et al., A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol Cell Biol 2009; 29: 3722-3737.
130. Smit MA, Peeper DS,. Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis. Oncogene 2011; 30: 3735-3744.
131. Mongroo PS, Rustgi AK,. The role of the miR-200 family in epithelial-mesenchymal transition. Cancer Biol Ther 2010; 10: 219-222.
132. Wellner U, Schubert J, Burk UC, et al., The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 2009; 11: 1487-1495.
133. Brabletz S, Brabletz T,. The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer? EMBO Rep 2010; 11: 670-677.
134. Aigner K, Dampier B, Descovich L, et al., The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 2007; 26: 6979-6988. (Pubitemid 350014612)
135. Graham TR, Zhau HE, Odero-Marah VA, et al., Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res 2008; 68: 2479-2488. (Pubitemid 351521824)
136. Spaderna S, Schmalhofer O, Hlubek F, et al., A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 2006; 131: 830-840. (Pubitemid 44307069)
137. Wang Z, Li Y, Ahmad A, et al., Targeting miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance. Drug Resist Updat 2010; 13: 109-118.
138. Tryndyak VP, Beland FA, Pogribny IP,. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Int J Cancer 2010; 126: 2575-2583.
139. Howe EN, Cochrane DR, Richer JK,. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res 2011; 13: R45.
140. Penna E, Orso F, Cimino D, et al., microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J 2011; 30: 1990-2007.
141. Cannito S, Novo E, Compagnone A, et al., Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis 2008; 29: 2267-2278.
142. Chandel NS, Maltepe E, Goldwasser E, et al., Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 1998; 95: 11715-11720. (Pubitemid 28460480)
143. Sullivan R, Graham CH,. Hypoxia-driven selection of the metastatic phenotype. Cancer Metast Rev 2007; 26: 319-331. (Pubitemid 47101665)
144. Li G, Satyamoorthy K, Herlyn M,. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res 2001; 61: 3819-3825. (Pubitemid 32694999)
145. Whelan KA, Caldwell SA, Shahriari KS, et al., Hypoxia suppression of Bim and Bmf blocks anoikis and luminal clearing during mammary morphogenesis. Mol Biol Cell 2010; 21: 3829-3837.
146. Beaufort N, Corvazier E, Hervieu A, et al., The thermolysin-like metalloproteinase and virulence factor LasB from pathogenic Pseudomonas aeruginosa induces anoikis of human vascular cells. Cell Microbiol 2011; 13: 1149-1167.
147. Kockx MM, Herman AG,. Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res 2000; 45: 736-746. (Pubitemid 30047141)
148. Walsh K, Smith RC, Kim HS,. Vascular cell apoptosis in remodeling, restenosis, and plaque rupture. Circ Res 2000; 87: 184-188. (Pubitemid 30626424)
149. Houard X, Monnot C, Dive V, et al., Vascular smooth muscle cells efficiently activate a new proteinase cascade involving plasminogen and fibronectin. J Cell Biochem 2003; 88: 1188-1201. (Pubitemid 36397457)
150. Meilhac O, Ho-Tin-Noe B, Houard X, et al., Pericellular plasmin induces smooth muscle cell anoikis. FASEB J 2003; 17: 1301-1303.
151. Fontaine V, Jacob MP, Houard X, et al., Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 2002; 161: 1701-1710. (Pubitemid 35265529)
152. Jacob MP, Cazaubon M, Scemama A, et al., Plasma matrix metalloproteinase-9 as a marker of blood stasis in varicose veins. Circulation 2002; 106: 535-538. (Pubitemid 34827700)
153. Arnould T, Michiels C, Remacle J,. Hypoxic human umbilical vein endothelial cells induce activation of adherent polymorphonuclear leukocytes. Blood 1994; 83: 3705-3716. (Pubitemid 24175562)
154. Michel JB,. Anoikis in the cardiovascular system: known and unknown extracellular mediators. Arterioscler Thromb Vasc Biol 2003; 23: 2146-2154.
155. Kochtebane N, Choqueux C, Passefort S, et al., Plasmin induces apoptosis of aortic valvular myofibroblasts. J Pathol 2010; 221: 37-48.
156. Otto CM, Kuusisto J, Reichenbach DD, et al., Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994; 90: 844-853. (Pubitemid 24242754)
157. Donnelly R, Emslie-Smith AM, Gardner ID, et al., ABC of arterial and venous disease: vascular complications of diabetes. Br Med J 2000; 320: 1062-1066. (Pubitemid 30198980)
158. Martin A, Komada MR, Sane DC,. Abnormal angiogenesis in diabetes mellitus. Med Res Rev 2003; 23: 117-145. (Pubitemid 36241095)
159. Dobler D, Ahmed N, Song L, et al., Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification. Diabetes 2006; 55: 1961-1969. (Pubitemid 44509968)
160. Thornalley PJ, Rabbani N,. Protein damage in diabetes and uremia-identifying hotspots of proteome damage where minimal modification is amplified to marked pathophysiological effect. Free Radic Res 2011; 45: 89-100.
161. Stitt AW, Hughes SJ, Canning P, et al., Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor. Diabetologia 2004; 47: 1735-1746. (Pubitemid 40022409)
162. Hughes JM, Kuiper EJ, Klaassen I, et al., Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina. Diabetologia 2007; 50: 1089-1098. (Pubitemid 46559257)
163. Liu H, Yang R, Tinner B, et al., Cysteine-rich protein 61 and connective tissue growth factor induce deadhesion and anoikis of retinal pericytes. Endocrinology 2008; 149: 1666-1677. (Pubitemid 351468326)
164. Freyman T, Polin G, Osman H, et al., A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 2006; 27: 1114-1122.
165. Toma C, Pittenger MF, Cahill KS, et al., Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002; 105: 93-98. (Pubitemid 34049148)
166. Nakamura Y, Yasuda T, Weisel RD, et al., Enhanced cell transplantation: preventing apoptosis increases cell survival and ventricular function. Am J Physiol Heart Circ Physiol 2006; 291: H939-947. (Pubitemid 44175104)
167. Sadek HA, Martin CM, Latif SS, et al., Bone-marrow-derived side population cells for myocardial regeneration. J Cardiovasc Transl Res 2009; 2: 173-181.
168. Suzuki K, Murtuza B, Beauchamp JR, et al., Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J 2004; 18: 1153-1155. (Pubitemid 39561554)
169. Schinkothe T, Bloch W, Schmidt A,. In vitro secreting profile of human mesenchymal stem cells. Stem Cells Dev 2008; 17: 199-206.
170. Copland IB, Lord-Dufour S, Cuerquis J, et al., Improved autograft survival of mesenchymal stromal cells by plasminogen activator inhibitor 1
171. Yao EH, Yu Y, Fukuda N,. Oxidative stress on progenitor and stem cells in cardiovascular diseases. Curr Pharm Biotechnol 2006; 7: 101-108. (Pubitemid 44110357)
172. Hahn JY, Cho HJ, Kang HJ, et al., Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol 2008; 51: 933-943.
173. Fiaschi T, Tedesco FS, Giannoni E, et al., Globular adiponectin as a complete mesoangioblast regulator: role in proliferation, survival, motility, and skeletal muscle differentiation. Mol Biol Cell 2010; 21: 848-859.
174. Sciorati C, Galvez BG, Brunelli S, et al., Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy. J Cell Sci 2006; 119: 5114-5123. (Pubitemid 46085190)
175. Gnecchi M, He H, Noiseux N, et al., Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006; 20: 661-669. (Pubitemid 44933310)
176. Mangi AA, Noiseux N, Kong D, et al., Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003; 9: 1195-1201. (Pubitemid 37173705)
177. Song H, Kwon K, Lim S, et al., Transfection of mesenchymal stem cells with the FGF-2 gene improves their survival under hypoxic conditions. Mol Cells 2005; 19: 402-407.
178. Tang YL, Tang Y, Zhang YC, et al., Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 2005; 46: 1339-1350. (Pubitemid 41615559)
179. Markel TA, Wang Y, Herrmann JL, et al., VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am J Physiol Heart Circ Physiol 2008; 295: H2308-2314.
180. Li W, Ma N, Ong LL, et al., Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 2007; 25: 2118-2127. (Pubitemid 47258191)